XXV Jornadas de Investigación FUNDALUCE 2023 en Madrid: Un Evento

The Minister of Health of the Community of Madrid, Fátima Matute, inaugurates on Friday the XXV Research Conference of the Foundation to Fight Blindness

MADRID, November 28, 2023 – A novel and promising twist in gene therapy is presented as hope for future treatments against blindness. The initiative, called NeurAll Project, which follows the “Development of a new multivalent non-viral vector for gene therapy of Hereditary Retinal Dystrophies (HRD) is pursued.” The work, coordinated by doctors Francisco Javier Díaz Corrales, researcher at the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER); and Silvia Hernández Ainsa, from the University of Zaragoza, have been awarded the 2022 FUNDALUCE Foundation to Fight Blindness Award. Both scientists will collect the award with the corresponding support during the celebration of the XXV Fundaluce Research Conference, this Friday, December 1, 2023, in the Aula Magna of the Jiménez Díaz Foundation University Hospital, in Madrid.

The main hall of the Foundation’s hospital will be the place that will host this meeting between specialists and patients starting at 5:30 p.m., with an institutional table that will be attended by Fátima Matute Teresa, Health Minister of the Community of Madrid; Javier Arcos Campillo, Manager and medical director of the Jiménez Díaz Foundation University Hospital; Imelda Fernández Rodríguez, Vice President of ONCE; and David Sánchez González, president of the Federation of Associations of Hereditary Retinal Dystrophies of Spain (FARPE) and its Foundation to Fight Blindness (FUNDALUCE).

The head doctor of the Genetics Service of the Jiménez Díaz Foundation, Carmen Ayuso García, president of the FARPE-FUNDALUCE Expert Advisory Committee, will be in charge of offering the conclusions of the conference, whose closing will be carried out by Albert Español Pujol, Vice president of the Retina Catalunya Association.

FUNDALUCE has been one of the main tools of patient associations in Spain for a quarter of a century to contribute and promote the development of research aimed at fighting blindness. Throughout all this time, it has distributed more than 700,000 euros from donations from the associations themselves, from individuals and companies among scientists for their research projects. This foundation is the valuable instrument with which those affected claim a leading role in the decision-making bodies regarding the development of research and clinical trials, as well as in the possible implementation of treatments that may arise in the future, which seems ever closer.

Newsletter Signup

To keep up to date with our news and activities,
please leave your details below

GDPR Compliance Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.